The ten largest shareholders of Renhe Group: 1. Renhe (Group) Development Co., Ltd., 2. Yang Xiao, 3. Cathay Fund-Bank of Communications-Cathay Fund Boyuan No. 20 Collective Venture, 4. Shanghai Pudong Development Bank Co., Ltd.-E Fund Innovation

Future, 5. Industrial and Commercial Bank of China Co., Ltd. - E Fund Kexiang hybrid certificate, 6. Bank of China Co., Ltd. - E Fund balanced growth stock certificate, 7. Renhe Pharmaceutical Co., Ltd. repurchase special securities account, 8. Basic

Pension Insurance Fund Portfolio 1205, 9. Bank of China-E Fund Stable Growth Securities Investment Fund, 10. Industrial and Commercial Bank of China Co., Ltd.-E Fund New Economy Flexible Allocation 1, Renhe Group Renhe (Group) Development Co., Ltd. was established in 2001

, is a modern pharmaceutical enterprise group dedicated to the research and development and promotion of traditional and high-tech pharmaceutical products. It owns 1 listed company, 8 key pharmaceutical production companies, 3 commercial logistics companies, and more than 5,000 employees.

Renhe Group was founded in 1998 and established in 2001.

With the cordial care of the party and governments at all levels and the enthusiastic help from all walks of life, and through the hard work of all employees, it has developed into a modern pharmaceutical enterprise group integrating the research and development, production and sales of drugs and health products.

Since its establishment, in terms of major economic indicators such as sales revenue and tax contribution, it has achieved excellent performance of doubling for 6 consecutive years and growing 66 times in 10 years.

2. The business scope of Renhe Group includes planting of Chinese medicinal materials, cultivation of medicinal seedlings, production and sales of cartons, computer software development, packaging design, advertising planning and production, building materials, home appliances and hardware, department stores, chemicals (except chemical dangerous goods), electromechanical (cars)

(excluding), electronic products, cultural and sports office supplies, communication equipment (except radio transmitting equipment), auto parts, metal materials wholesale and retail, industrial investment, capital operation, project consulting services; office buildings and factory leases.

(Projects that must be approved according to law can only carry out business activities after approval by relevant departments) Renhe Industrial Enterprise has a modern production base covering a total area of ??more than 600,000 square meters, and has registered to produce more than 400 varieties of Chinese and Western medicines and health care products.

There are 29 pharmaceutical dosage forms such as capsules, soft capsules, pills, eye drops, granules, tablets, lotions, and rubber ointments and 8 health food dosage forms that have obtained national GMP certifications, forming a comprehensive network of both drugs and health products.

Major product production sector.